This inventor holds 36 USPTO granted patents, plus 1 CIPO patent, primarily in Pharmaceutical Chemistry. Top assignees: American Home Products Corporation, Wyeth, John Wyeth & Bro., Limited. Active years: 1976-2007.
Location History:
- Gulph Mills, PA (US) (1985 - 1996)
- King of Prussia, PA (US) (1976 - 2007)
Company Filing History:
31 out of 1,567 
5 out of 1,309 
1 out of 2 Years Active: 1976-2007
Areas of Expertise:
Title: John P. Yardley: Innovator in Pharmaceutical Chemistry
Introduction
John P. Yardley, a prominent inventor based in Gulph Mills, Pennsylvania, holds an impressive portfolio of 36 patents. His work focuses primarily on innovative pharmaceutical compounds that contribute to advancements in medicinal chemistry.
Latest Patents
Among Yardley's latest inventions are significant contributions to the field of pharmacology. One of his notable patents is for "Ethers of O-desmethyl venlafaxine". This innovative compound provides O-α-acyloxyalkyl ethers of the venlafaxine metabolite 4-[2-(Dimethylamino-1-(1-hydroxycyclohexyl)ethyl]phenol, which is represented by a specific formula detailing various variables and configurations at the stereogenic center. Additionally, Yardley has developed "Branched adamantyl and noradamantyl aryl- and aralkylpiperazines with serotonin 5-HT1A activity", enhancing the exploration of therapeutic targets in treating various psychiatric disorders.
Career Highlights
Throughout his career, John P. Yardley has made significant contributions while working with renowned companies such as American Home Products Corporation and Wyeth. His dedication to pharmaceutical innovation has positioned him as a valuable asset in the industry.
Collaborations
Yardley's collaborations with esteemed colleagues have further enriched his research and development efforts. Notable coworkers include Magid A. Abou-Gharbia and Wayne E. Childers, Jr., who have partnered with him in various projects, pushing the boundaries of pharmaceutical science.
Conclusion
John P. Yardley's extensive contributions to medicinal chemistry through his numerous patents illustrate his role as a key innovator in the field. His ongoing research and collaboration with industry leaders continue to foster advancements that benefit healthcare and patient outcomes.